{"id":"W4416187331","doi":"10.1080/14796694.2025.2577633","title":"Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Bayer","keywords":"Biochemical recurrence; Prostate cancer; Clinical endpoint; Prostatectomy; Prostate-specific antigen; Placebo; Radiation therapy; Glutamate carboxypeptidase II; Adjuvant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001967851,0.0001241294,0.0003883162,0.0002023268,0.00003452147,0.000003962461,0.00009584533,0.0002084951,0.00007975451],"category_scores_gemma":[0.00004827779,0.00009107084,0.00004730759,0.0005389376,0.0001425525,0.00003740819,0.00004378616,0.0003393603,0.000003951087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000543925,"about_ca_system_score_gemma":0.001034196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004811288,"about_ca_topic_score_gemma":0.0001892703,"domain_scores_codex":[0.9989424,0.0000962511,0.0002715142,0.0002810391,0.000149822,0.0002590031],"domain_scores_gemma":[0.9994205,0.00007964455,0.000104625,0.0002031667,0.0001344411,0.00005759409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00796134,0.0005441803,0.580416,0.0002066962,0.0002313241,0.00007356173,0.001128273,0.00001825607,0.0253837,0.0005739774,0.007964829,0.3754979],"study_design_scores_gemma":[0.03457401,0.003327279,0.6021405,0.000647845,0.0001488058,0.00001977129,0.0007213714,0.0002592302,0.2335272,0.002130896,0.1221953,0.0003078404],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977561,0.01374196,0.00001285042,0.006481208,0.0004734232,0.0007867525,0.00004704241,0.00002126359,0.0008744804],"genre_scores_gemma":[0.9717036,0.0264667,0.0003279878,0.0002818094,0.0002141241,0.0002234933,0.00008463108,0.00001067263,0.0006868998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.37519,"threshold_uncertainty_score":0.3713761,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01653389836474592,"score_gpt":0.3473627806221141,"score_spread":0.3308288822573682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}